| LPS | lipopolysaccharide |
| LS-G | LPS sustained-release gelatin sponge |
| EGCG | epigallocatechin gallate |
| D+Q | dasatinib and quercetin |
| CBSD | critical-sized bone defect |
| OA | oral administration |
| LPS | lipopolysaccharide |
| LS-G | LPS sustained-release gelatin sponge |
| EGCG | epigallocatechin gallate |
| D+Q | dasatinib and quercetin |
| CBSD | critical-sized bone defect |
| OA | oral administration |